Medical Policy Updates

Table Of Contents

Notification of Policy Revisions Effective December 28, 2012 (Posted September 18, 2012)

Medical Policy Revision
Intravenous Anesthetics for the Treatment of Chronic Pain "Notification" Evidence based guideline converted to corporate medical policy. Intravenous infusion of anesthetics (e.g., ketamine or lidocaine) for the treatment of chronic pain, including, but not limited to chronic neuropathic pain and fibromyalgia, is considered investigational. Medical Director review 8/21/12. Notification given 9/18/2012 Policy effective 12/28/2012.